AF
Allworth Financial Portfolio holdings
AUM
$20.8B
1-Year Return
12.38%
This Quarter Return
+9.88%
1 Year Return
+12.38%
3 Year Return
+38.45%
5 Year Return
+53.41%
10 Year Return
+94.66%
AUM
$3.81B
AUM Growth
+$492M
(+15%)
Cap. Flow
+$152M
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
69.82%
Holding
1,486
New
242
Increased
382
Reduced
190
Closed
49
Top Buys
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
$131M |
| 2 |
SPDR Portfolio Developed World ex-US ETF
SPDW
|
$118M |
| 3 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
$79.6M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
$76.8M |
| 5 |
Vanguard Total Bond Market
BND
|
$41.1M |
Top Sells
Sector Composition
| 1 | Technology | 1.7% |
| 2 | Financials | 0.79% |
| 3 | Communication Services | 0.62% |
| 4 | Real Estate | 0.5% |
| 5 | Healthcare | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
iShares Core Moderate Allocation ETF
AOM
$1.59B
| $201K | 0.01% |
+4,663
| New | +$201K |
|
277
Northrop Grumman
NOC
$83.2B
| $196K | 0.01% |
642
-43
| -6% | -$13.1K |
|
278
Constellation Brands
STZ
$26.2B
| $196K | 0.01% |
893
+3
| +0.3% | +$658 |
|
279
Airbnb
ABNB
$75.8B
| $191K | 0.01% |
+1,300
| New | +$191K |
|
|
PARA
280
DELISTED
Paramount Global Class B
PARA
| $189K | 0.01% |
5,071
+41
| +0.8% | +$1.53K |
|
281
Vanguard Mid-Cap Value ETF
VOE
$18.8B
| $189K | 0.01% |
1,591
+111
| +8% | +$13.2K |
|
|
MXIM
282
DELISTED
Maxim Integrated Products
MXIM
| $189K | 0.01% |
2,131
| – | – |
|
283
Vanguard Russell 2000 ETF
VTWO
$12.8B
| $188K | ﹤0.01% |
+2,378
| New | +$188K |
|
284
SPDR S&P Dividend ETF
SDY
$20.5B
| $184K | ﹤0.01% |
1,739
+12
| +0.7% | +$1.27K |
|
285
Qualcomm
QCOM
$172B
| $182K | ﹤0.01% |
1,197
+382
| +47% | +$58.1K |
|
286
Veeva Systems
VEEV
$44.7B
| $181K | ﹤0.01% |
665
+12
| +2% | +$3.27K |
|
287
Yum! Brands
YUM
$40.1B
| $181K | ﹤0.01% |
1,668
+1
| +0.1% | +$109 |
|
288
Morgan Stanley
MS
$236B
| $180K | ﹤0.01% |
2,621
+109
| +4% | +$7.49K |
|
289
Stryker
SYK
$150B
| $178K | ﹤0.01% |
728
+25
| +4% | +$6.11K |
|
290
Colgate-Palmolive
CL
$68.8B
| $176K | ﹤0.01% |
2,060
+130
| +7% | +$11.1K |
|
291
Linde
LIN
$220B
| $176K | ﹤0.01% |
668
+112
| +20% | +$29.5K |
|
292
Lam Research
LRCX
$130B
| $176K | ﹤0.01% |
3,730
-1,000
| -21% | -$47.2K |
|
293
VeriSign
VRSN
$26.2B
| $175K | ﹤0.01% |
807
+1
| +0.1% | +$217 |
|
294
ARK Web x.0 ETF
ARKW
$2.33B
| $174K | ﹤0.01% |
1,190
| – | – |
|
295
Progressive
PGR
$143B
| $170K | ﹤0.01% |
1,720
+2
| +0.1% | +$198 |
|
296
Biogen
BIIB
$20.6B
| $169K | ﹤0.01% |
691
| – | – |
|
297
Enterprise Products Partners
EPD
$68.6B
| $169K | ﹤0.01% |
8,634
+200
| +2% | +$3.92K |
|
298
First Trust Dorsey Wright Focus 5 ETF
FV
$3.71B
| $169K | ﹤0.01% |
4,181
| – | – |
|
299
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
$1.29B
| $167K | ﹤0.01% |
2,993
+6
| +0.2% | +$335 |
|
300
CVS Health
CVS
$93.6B
| $167K | ﹤0.01% |
2,443
+255
| +12% | +$17.4K |
|